Other Events ·
GSK plc announced that the European Medicines Agency has accepted a submission to update the Bexsero label to include…
GSKGSK plc
GSK plc announced that the European Medicines Agency has accepted a submission to update the Bexsero label to include a single-dose booster for individuals aged 10 years and older. The submission is supported by Phase 3b study data showing the booster dose is effective in boosting immune responses in individuals previously vaccinated during infancy. GSK is a global biopharma company that develops and distributes vaccines and medicines to fight disease.